Fresh, Uncultured Autologous Adipose-Derived Regenerative Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fresh, Uncultured Autologous Adipose-Derived Regenerative Cells, covering 2024-12-03 to 2024-12-03. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate. [Phase 2]